H.R. 5381 · 116th Congress
International Pharmaceutical Transparency Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
DesJarlaisSponsorNo cosponsors.
This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.
What it does: CRS summary · Introduced in House · Dec 10, 2019
International Pharmaceutical Transparency Act of 2019
This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: International Pharmaceutical Transparency Act of 2019
Latest action (Dec 11, 2019): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Dec 10, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.